Anondita Medicare Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Net Income	157.94	38.45	3.47
Depreciation & Amortization	9.27	6.57	6.26
Other Amortization	0.01	-	-
Loss (Gain) From Sale of Assets	0.09	-	-
Other Operating Activities	84.15	45.95	27.36
Change in Accounts Receivable	-111.38	6.63	-106.01
Change in Inventory	-27.64	3.75	-5.81
Change in Accounts Payable	-15.98	4.54	-19.01
Change in Other Net Operating Assets	-201.11	-0.4	-1.22
Operating Cash Flow	-104.66	105.49	-94.96
Capital Expenditures	-70.09	-40.43	-2.99
Sale of Property, Plant & Equipment	0.42	-	-
Cash Acquisitions	-114.57	-	-
Investment in Securities	-2.02	-	-
Other Investing Activities	-42.84	-24.98	0.46
Investing Cash Flow	-229.1	-65.42	-2.53
Short-Term Debt Issued	137.43	-	52.05
Long-Term Debt Issued	9.14	13.51	13.8
Total Debt Issued	146.57	13.51	65.85
Short-Term Debt Repaid	-	-0.01	-
Total Debt Repaid	-	-0.01	-
Net Debt Issued (Repaid)	146.57	13.5	65.85
Issuance of Common Stock	234.07	-	60.32
Repurchase of Common Stock	-	-19.44	-
Other Financing Activities	-48.32	-34.06	-27.1
Financing Cash Flow	332.32	-40	99.07
Miscellaneous Cash Flow Adjustments	-	0	-
Net Cash Flow	-1.43	0.08	1.58
Free Cash Flow	-174.75	65.06	-97.95
Free Cash Flow Margin	-22.70%	14.01%	-27.27%
Free Cash Flow Per Share	-15.53	4.89	-
Cash Interest Paid	27.28	31.48	24.48
Cash Income Tax Paid	6.64	-	-
Levered Free Cash Flow	-187.03	-0.96	-
Unlevered Free Cash Flow	-169.79	18.98	-
Change in Working Capital	-356.11	14.53	-132.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.